All other factors, namely platelet count, TLC, PB and BM blast %, BM cellularity and lymphocyte%, IPT, lymphadenopathy, hepatomegaly, splenomegaly, molecular genetics, cytogenetic risk stratification, CD34+, CD34+/CD38-, CD4+/CD3+, CD8+/CD3+, CD4/CD8 ratio and MRD had no impact on PFS. The gene discussed is CD34; the disease is Lymphadenopathy.